EDGAR Filing Documents for 0001209191-17-026944

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-17-026944

Filing Date

2017-04-13

Accepted

2017-04-13 19:12:51

Documents

Period of Report

2017-04-12

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	3914
	Complete submission text file	0001209191-17-026944.txt		5360

Mailing Address 575 HIGH STREET STE 201 PALO ALTO CA 94301

Business Address

Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 17761885

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)